{"@context":"https://schema.org","@type":"Article","headline":"Part 2 consent copy accompanying disclosure","description":"Learn when a copy of written Part 2 consent accompanies a disclosure and how practices protect unnecessary fields while proving the released scope.","url":"https://finnihealth.com/resources/glossary/part-2-consent-copy-accompanying-disclosure","datePublished":"2026-08-17T00:00:00.000Z","dateModified":"2026-08-24T00:00:00.000Z","author":{"@type":"Organization","name":"Finni Health Editorial Team"},"publisher":{"@type":"Organization","name":"Finni Health","url":"https://www.finnihealth.com"},"isPartOf":{"@type":"CollectionPage","name":"ABA and Practice Operations Glossary","url":"https://www.finnihealth.com/resources/glossary"},"breadcrumb":{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Resources","item":"https://www.finnihealth.com/resources"},{"@type":"ListItem","position":2,"name":"Glossary","item":"https://www.finnihealth.com/resources/glossary"},{"@type":"ListItem","position":3,"name":"Part 2 consent copy accompanying disclosure","item":"https://finnihealth.com/resources/glossary/part-2-consent-copy-accompanying-disclosure"}]}}
Glossary term

Part 2 consent copy accompanying disclosure

Learn when a copy of written Part 2 consent accompanies a disclosure and how practices protect unnecessary fields while proving the released scope.

5
min read
Updated
August 23, 2026
Sources checked
August 23, 2026
· View sources
Also called

SUD disclosure consent attachment Part 2 consent copy

Consent copy disclosure describes one way to satisfy the Part 2 requirement that every disclosure made with written consent include either a copy of that consent or a clear explanation of its scope. This item is required in addition to the detailed or short accompanying notice. The copy helps the recipient understand authorized records, purpose, recipient, expiration, and other boundaries represented in the signed consent.

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Two companion requirements apply

42 CFR 2.32 requires one approved written statement and, separately, a consent copy or clear scope explanation. A release engine should test both controls. Finding Statement 1 or Statement 2 does not prove the consent-scope item is present.

Represent the package as distinct required components rather than one “confidentiality attached” checkbox. Record the notice version, consent or explanation selection, exact artifact, records, recipient, secure destination, sender, time, and delivery status. Block transmission when the selected scope item is absent, mismatched, or inaccessible.

The copy helps a recipient interpret authority, but it does not replace the disclosure review. The sender still validates the written consent, proposed action, Part 2 record status, specialized rules, and every other applicable condition.

Use the operative consent version

Verify that the copy belongs to the patient and disclosure, contains the required 42 CFR 2.31 elements, was effective at release, and reflects any revocation or restriction affecting the action. Preserve the authoritative signed artifact and the exact copy transmitted.

Match patient, signer, authority, authorized discloser, meaningful record description, recipient or supported class, purpose, expiration, signature date, and material limitations. Compare the requested records and actual destination with those terms immediately before assembly. A consent for one provider, date range, or purpose cannot accompany a different release merely because the patient's name matches.

Use a durable consent identifier and version hash. Preserve the signed form as it appeared at execution, along with correction, clarification, revocation, expiration, and supersession history. Do not regenerate a cleaner-looking copy that changes the signed evidence.

Protect information outside the needed scope

A consent copy may reveal signatures, contact details, or choices beyond the recipient's immediate task. Compare the copy option with a clear scope explanation under approved privacy policy. Redaction must never alter or obscure a term the recipient needs to understand the authority.

Identify other recipients, unrelated purposes, protected contact information, proxy details, handwriting, attachment pages, optional selections, and metadata that may appear on the form. Qualified policy should decide whether the full copy, a properly minimized copy, or a clear scope explanation is appropriate. Preserve the unaltered authoritative consent even when the transmitted artifact is limited.

Use controlled redaction with a reviewer, reason, version, and final check. Avoid black boxes that can be removed, comments that reveal hidden text, or cropping that removes context. A recipient should be able to understand every boundary relevant to the records received.

Secure and test the attachment

Keep the consent copy inside the protected package and avoid unsafe filenames, email subjects, fax labels, or open links that reveal Part 2 status. Test portal, secure email, fax, paper, HIE, API, vendor exchange, download, print, retry, and partial failure. Confirm recipient access and association with the correct records.

If a wrong version, wrong patient, missing page, detached artifact, inaccessible link, or excessive disclosure is found, stop or contain access, preserve evidence, correct the package, and assess earlier events using the same route or selection logic.

Example with package matching

Twenty consented disclosures reach final assembly. Eighteen have the matching operative consent copy; one has the wrong version and one has no consent-scope item. Copy readiness is 18 of 20 packages. Both failed packages remain in the denominator and on hold.

The program retrieves the correct operative copy for the first package and adds the missing scope item to the second after revalidating consent. It reviews why version selection failed, tests similar records, and preserves the initial 18-of-20 result alongside the later correction.

Consent-copy checklist

  • Require an approved notice and a separate consent-scope item.
  • Match the copy to patient, consent version, recipient, purpose, and records.
  • Preserve signed evidence, corrections, revocation, and supersession history.
  • Minimize unrelated fields without obscuring operative terms.
  • Secure the artifact and test every transmission and recipient view.
  • Hold wrong, missing, incomplete, detached, or inaccessible copies.
  • Correct selection logic and review affected prior packages.

Owner controls

The 2024 final rule provides current context. Use consent identifiers, version hashes, patient and recipient matching, revocation checks, minimum-content review, secure attachment, package logs, and exception escalation.

Monitor copy selection, version mismatches, redactions, missing pages, attachment failures, recipient questions, held packages, and corrections. Audit from disclosures back to the exact transmitted copy and from active consent versions into release-system mappings. Retest after form, portal, interface, vendor, or document-management changes.

Related terms

Sources

Beyond the glossary

Take the next step with clarity

Whether you are finding care, growing as a clinician, or building a stronger ABA practice, Finni brings the people, tools, and support together to help you move forward.

Start or grow your ABA practice with Finni